MedPath

The efficacy of hydrogen gas inhalation during Perctaneous Coronary Intervention in patients with ST elevation acute myocardial infarctio

Not Applicable
Conditions
Acute myocardial infarction
Registration Number
JPRN-UMIN000014390
Lead Sponsor
ational Center for Global Health and Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Shock (BP<90mmHg) Patient of Congestive Heart Failure or Severe hypoxia (SpO2<94% using nasal 4l O2 inhale) Sustained VT or VF Post-cardiopulmonary resuscitation Patients with absolute contraindications to MRI scans The patient who is not provided of the written agreement. The patient who judged a trial entry doctor to be inappropriate as an object of the final examination.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the extent of myocardial ischemia-reperfusion injury by cardiovascular magnetic resonance imaging 30 days after acute myocardial infarction
Secondary Outcome Measures
NameTimeMethod
Angiographic assessment of reperfision by TIMI flow grade and myocardial blush grade. Assessment of reperfusion by ST resolution comparison of prePCI and post PCI. Assessment of infarct size by creatine phosphokinase (CPK). Assessment of left ventricular failure by Killip classification. Evaluation of left ventricular ejection fraction and infarct size by cardiac MRI imaging in chronic phase. Assesment of major advance cardiac event.
© Copyright 2025. All Rights Reserved by MedPath